Pascal S. Krenger
Bern, BE 3008, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.
Journal: Viruses
Published: July 11, 2025
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874.
Journal: Vaccines
Published: October 07, 2024
Regulatory T cells define affinity thresholds for CD8+ T cell tumor infiltration.
Journal: NPJ vaccines
Published: August 02, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.
Journal: Vaccines
Published: July 23, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic response.
Journal: Allergy
Published: February 26, 2024
BALB/c and C3H mice are both suitable as peanut allergy models.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 16, 2023
The next generation virus-like particle platform for the treatment of peanut allergy.
Journal: Allergy
Published: August 09, 2022
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.
Journal: Frontiers in immunology
Published: January 28, 2022
Last Updated: 09/26/2026